ghk cu peptide injection prescription GHK-Cu Injectable GHK-CU COPPER PEPTIDE 5MG/10MG/50MG/100MG VIAL

Analytical Identity Copper Tripeptide-1 (GHK-Cu, CAS 89030-95-5) is a naturally occurring copper-binding tripeptide - glycyl-L-histidyl-L-lysine chelated to a divalent copper ion (Cu2+) - first identified in human plasma, where its concentration has been reported to decline with age, and later characterized in saliva and other biological fluids

Clinical trials demonstrate that GHK-Cu skin serum can help reduce the effects of UV radiation

TP73 increases by 938%, while USP29 (which stabilizes p53) increases by 1,056%

Recovery Science and Regenerative Biology The peptide industry continues expanding as researchers investigate advanced peptide combinations for recovery-focused laboratory studies

Research interest nonetheless expanded considerably through the 1980s and 1990s, as investigators began exploring DSIP's broader neuroendocrine roles, including its interactions with the HPA axis, circadian timing systems, and stress-response pathways, establishing the compound as a multifunctional regulatory neuropeptide whose biological significance extends well beyond its original sleep-focused characterization